Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Helicobacter pylori and gastroduodenal ulcer disease.

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Kist M, Koletzko S; Association of Scientific Medical Societies..

Dtsch Arztebl Int. 2009 Dec;106(49):801-8. doi: 10.3238/arztebl.2009.0801.

2.

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001.

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke S, Morgner A, Peitz U, Preiss J, Prinz C, Rosien U, Schmidt W, Schwarzer A, Suerbaum S, Timmer A, Treiber G, Vieth M; German society for hygiene and microbiology.; German society for pediatric gastroenterology and nutrition e. V.; German society for rheumatology..

Z Gastroenterol. 2009 Dec;47(12):1230-63. doi: 10.1055/s-0028-1109855.

PMID:
19960402
3.

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G; European Helicobacter Pylori Study Group (EHPSG)..

Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. Review.

4.

[Short version of the S3 (level 3) guideline "Helicobacter pylori and gastroduodenal ulcer disease" from the German Society for Digestive and Metabolic Diseases].

Fischbach W; Leitliniengruppe der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.; Deutschen Gesellschaft für Hygiene und Mikrobiologie.; Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e. V.; Deutschen Gesellschaft für Rheumatologie..

Dtsch Med Wochenschr. 2009 Sep;134(37):1830-4. doi: 10.1055/s-0029-1237521. German.

PMID:
19728254
5.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

6.

Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests.

Nocon M, Kuhlmann A, Leodolter A, Roll S, Vauth C, Willich SN, Greiner W.

GMS Health Technol Assess. 2009 Oct 21;5:Doc14. doi: 10.3205/hta000076.

7.

[Helicobacter pylori].

Fischbach W.

Internist (Berl). 2009 Aug;50(8):979-86; quiz 987. doi: 10.1007/s00108-009-2438-3. Review. German.

PMID:
19609771
8.

[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"].

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke S, Morgner A, Peitz U, Preiss JC, Prinz C, Rosien U, Schmidt WE, Schwarzer A, Suerbaum S, Timmer A, Treiber G, Vieth M.

Z Gastroenterol. 2009 Jan;47(1):68-102. doi: 10.1055/s-0028-1109062. German.

PMID:
19156594
9.

Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.

Suzuki H, Masaoka T, Nomura S, Hoshino Y, Kurabayashi K, Minegishi Y, Suzuki M, Ishii H.

Keio J Med. 2003 Sep;52(3):163-73. Review.

10.

Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.

Chiba N, Lahaie R, Fedorak RN, Bailey R, Veldhuyzen van Zanten SJ, Bernucci B.

Can Fam Physician. 1998 Jul;44:1481-8. Review.

11.

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA; Second Asia-Pacific Conference..

J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600. doi: 10.1111/j.1440-1746.2009.05982.x.

PMID:
19788600
12.

[The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases].

Martínez-Sánchez G, Saperas E, Benavent J, Mearin F, Piñol JL, Barenys M, Mascort JJ, Forné M, Bordas JM, Azagra R, Piqué JM.

Gastroenterol Hepatol. 1998 Dec;21(10):473-8. Spanish.

PMID:
9927791
13.

Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.

Nakajima S, Graham DY, Hattori T, Bamba T.

Curr Pharm Des. 2000 Oct;6(15):1503-14. Review.

PMID:
10974147
14.

Guidelines in the medical treatment of Helicobacter pylori infection.

Dzieniszewski J, Jarosz M.

J Physiol Pharmacol. 2006 Sep;57 Suppl 3:143-54.

16.
17.

[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].

Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS; Korean College of Helicobacter and Upper Gastrointestinal Research.; Korean Association of Gastroenterology..

Korean J Gastroenterol. 2009 Nov;54(5):269-78. Korean.

18.
19.

[Diagnosis of Helicobacter pylori infections--how, when and in whom?].

Wildner-Christensen M, Schaffalitzky de Muckadell OB.

Ugeskr Laeger. 2000 Jun 26;162(26):3743-7. Review. Danish.

PMID:
10925639
20.

Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.

Konturek SJ, Bielański W, Płonka M, Pawlik T, Pepera J, Konturek PC, Czarnecki J, Penar A, Jedrychowski W.

Scand J Gastroenterol. 2003 Sep;38(9):923-30.

PMID:
14531527
Items per page

Supplemental Content

Support Center